Treatment of liver cancer
Journal
Cold Spring Harbor Perspectives in Medicine
Journal Volume
5
Journal Issue
9
Pages
a021535
Date Issued
2015
Author(s)
Abstract
Primary liver cancer, mostly hepatocellular carcinoma, remains a difficult-to-treat cancer. Incidence of liver cancer varies geographically and parallels with the geographic prevalence of viral hepatitis. A number of staging systems have been developed, reflecting the heterogeneity of primary liver cancer, regional preferences, and regional variations in resectability or transplant eligibility. Multimodality treatments are available for this heterogeneous malignancy, and there are variations in the management recommendations for liver cancers across specialties and geographic regions. Novel treatment strategies have merged with the advance of newtreatment modalities. Thiswork focuses on reviewing the incidence, staging, and treatment of liver cancer. ? 2015 Cold Spring Harbor Laboratory Press; all rights reserved.
SDGs
Other Subjects
cytotoxic agent; sorafenib; antineoplastic agent; Article; cancer chemotherapy; cancer incidence; cancer staging; cancer surgery; human; liver cancer; liver cell carcinoma; liver transplantation; oncolytic virotherapy; Carcinoma, Hepatocellular; catheter ablation; immunotherapy; Liver Neoplasms; liver resection; molecularly targeted therapy; multimodality cancer therapy; pathology; procedures; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Combined Modality Therapy; Hepatectomy; Humans; Immunotherapy; Liver Neoplasms; Liver Transplantation; Molecular Targeted Therapy; Neoplasm Staging; Oncolytic Virotherapy
Publisher
Cold Spring Harbor Laboratory Press
Type
journal article